| Convalescent plasma in Covid-19: Possible mechanisms of action M Rojas, Y Rodríguez, DM Monsalve, Y Acosta-Ampudia, B Camacho, ... Autoimmunity reviews 19 (7), 102554, 2020 | 595 | 2020 |
| Molecular mimicry and autoimmunity M Rojas, P Restrepo-Jiménez, DM Monsalve, Y Pacheco, ... Journal of autoimmunity 95, 100-123, 2018 | 574 | 2018 |
| Autoinflammatory and autoimmune conditions at the crossroad of COVID-19 Y Rodríguez, L Novelli, M Rojas, M De Santis, Y Acosta-Ampudia, ... Journal of autoimmunity 114, 102506, 2020 | 365 | 2020 |
| Post-COVID syndrome. A case series and comprehensive review JM Anaya, M Rojas, ML Salinas, Y Rodríguez, G Roa, M Lozano, ... Autoimmunity reviews 20 (11), 102947, 2021 | 291 | 2021 |
| Original antigenic sin: a comprehensive review A Vatti, DM Monsalve, Y Pacheco, C Chang, JM Anaya, ME Gershwin Journal of autoimmunity 83, 12-21, 2017 | 227 | 2017 |
| Bystander activation and autoimmunity Y Pacheco, Y Acosta-Ampudia, DM Monsalve, C Chang, ME Gershwin, ... Journal of autoimmunity 103, 102301, 2019 | 190 | 2019 |
| Mayaro: an emerging viral threat? Y Acosta-Ampudia, DM Monsalve, Y Rodríguez, Y Pacheco, JM Anaya, ... Emerging microbes & infections 7 (1), 1-11, 2018 | 170 | 2018 |
| The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022 | 155 | 2022 |
| Autoimmunity is a hallmark of post-COVID syndrome M Rojas, Y Rodríguez, Y Acosta-Ampudia, DM Monsalve, C Zhu, QZ Li, ... Journal of translational medicine 20 (1), 129, 2022 | 146 | 2022 |
| Guillain–Barré syndrome, transverse myelitis and infectious diseases Y Rodríguez, M Rojas, Y Pacheco, Y Acosta-Ampudia, ... Cellular & molecular immunology 15 (6), 547-562, 2018 | 146 | 2018 |
| Persistent autoimmune activation and proinflammatory state in post-coronavirus disease 2019 syndrome Y Acosta-Ampudia, DM Monsalve, M Rojas, Y Rodríguez, E Zapata, ... The Journal of infectious diseases 225 (12), 2155-2162, 2022 | 138 | 2022 |
| COVID-19 convalescent plasma composition and immunological effects in severe patients Y Acosta-Ampudia, DM Monsalve, M Rojas, Y Rodríguez, JE Gallo, ... Journal of autoimmunity 118, 102598, 2021 | 128 | 2021 |
| Ebola virus disease: An emerging and re-emerging viral threat M Rojas, DM Monsalve, Y Pacheco, Y Acosta-Ampudia, ... Journal of autoimmunity 106, 102375, 2020 | 111 | 2020 |
| A comprehensive analysis and immunobiology of autoimmune neurological syndromes during the Zika virus outbreak in Cúcuta, Colombia JM Anaya, Y Rodríguez, DM Monsalve, D Vega, E Ojeda, ... Journal of autoimmunity 77, 123-138, 2017 | 90 | 2017 |
| VRK1 chromatin kinase phosphorylates H2AX and is required for foci formation induced by DNA damage M Salzano, M Sanz-García, DM Monsalve, DS Moura, PA Lazo Epigenetics 10 (5), 373-383, 2015 | 72 | 2015 |
| Cytokine and autoantibody clusters interaction in systemic lupus erythematosus Y Pacheco, J Barahona-Correa, DM Monsalve, Y Acosta-Ampudia, ... Journal of Translational Medicine 15, 1-15, 2017 | 71 | 2017 |
| Autoimmune neurological conditions associated with Zika virus infection Y Acosta-Ampudia, DM Monsalve, LF Castillo-Medina, Y Rodríguez, ... Frontiers in molecular neuroscience 11, 116, 2018 | 70 | 2018 |
| Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials C Axfors, P Janiaud, AM Schmitt, J van’t Hooft, ER Smith, NA Haber, ... BMC infectious diseases 21, 1-23, 2021 | 67 | 2021 |
| Vaccinia-related Kinase 1 (VRK1) is an upstream nucleosomal kinase required for the assembly of 53BP1 foci in response to ionizing radiation-induced DNA damage M Sanz-García, DM Monsalve, A Sevilla, PA Lazo Journal of Biological Chemistry 287 (28), 23757-23768, 2012 | 64 | 2012 |
| Human VRK2 modulates apoptosis by interaction with Bcl-xL and regulation of BAX gene expression DM Monsalve, T Merced, IF Fernández, S Blanco, M Vázquez-Cedeira, ... Cell death & disease 4 (2), e513-e513, 2013 | 63 | 2013 |
Juan-Manuel Anaya / ORCID: 0000-00...Centro de Investigación e Innovación en Salud (CIISA), Coosalud, EPS, ColombiaEmail verificata su coosalud.com